Development and validation of a new high-performance liquid chromatographic estimation method of meloxicam in biological samples

J Chromatogr B Biomed Sci Appl. 2000 Feb 11;738(2):431-6. doi: 10.1016/s0378-4347(99)00537-x.

Abstract

A simple, HPLC method was developed to estimate meloxicam (COX-2 inhibitor) using piroxicam as the internal standard. The mobile phase containing methanol, acetonitrile and an aqueous solution of diammonium hydrogenorthophosphate (50 mM) in the ratio of 4:1:5 was pumped at the rate 1 ml/min. Lichrocart RP-18 (125 x 4 mm) was used as an analytical column and the analytes were detected at 364 nm using a UV detector. Acidified plasma samples were extracted with chloroform, evaporated to dryness, reconstituted in the mobile phase and then a volume of 10 microl of the prepared sample was injected in the column. The retention time of meloxicam and piroxicam was found to be 2.7 and 1.9, respectively. This method showed an accuracy of 102.3% at 0.52 microg/ml and was capable of detecting a minimum concentration of 0.029 microg/ml meloxicam from biological samples. The analytical method was successfully utilized for estimating meloxicam in biological samples.

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Cyclooxygenase Inhibitors / blood*
  • Cyclooxygenase Inhibitors / pharmacokinetics
  • Male
  • Meloxicam
  • Rats
  • Rats, Wistar
  • Reference Standards
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet
  • Thiazines / blood*
  • Thiazines / pharmacokinetics
  • Thiazoles / blood*
  • Thiazoles / pharmacokinetics

Substances

  • Cyclooxygenase Inhibitors
  • Thiazines
  • Thiazoles
  • Meloxicam